Skip to main content
icon for 2026年美国麻疹病例?

2026年美国麻疹病例?

icon for 2026年美国麻疹病例?

2026年美国麻疹病例?

Polymarket

$7,830,948 交易量

Polymarket

$7,830,948 交易量

↑4.5千

$20 交易量

42%

↑3千

$90,114 交易量

95%

↑3.5千

$13,530 交易量

93%

↑4千

$220,549 交易量

75%

↑5千

$230,428 交易量

26%

↑7.5k

$185,031 交易量

12%

↑1万

$6,515,593 交易量

6%

↑1.25万

$349,917 交易量

5%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991. This surge stems from sustained community transmission in under-vaccinated populations, with 94% of cases linked to 38 new outbreaks and many carrying over from late-2025 clusters; 20% involve children under five. Imported cases from international travel continue seeding local spread amid global measles activity. The CDC’s Advisory Committee on Immunization Practices is reviewing elimination status this month, while weekly case reports and state surveillance updates through year-end will determine final totals and any shifts in transmission dynamics.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,830,948
结束日期
2026-12-31
市场开放时间
Feb 16, 2026, 11:51 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991. This surge stems from sustained community transmission in under-vaccinated populations, with 94% of cases linked to 38 new outbreaks and many carrying over from late-2025 clusters; 20% involve children under five. Imported cases from international travel continue seeding local spread amid global measles activity. The CDC’s Advisory Committee on Immunization Practices is reviewing elimination status this month, while weekly case reports and state surveillance updates through year-end will determine final totals and any shifts in transmission dynamics.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,830,948
结束日期
2026-12-31
市场开放时间
Feb 16, 2026, 11:51 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

警惕外部链接哦。

常见问题

"2026年美国麻疹病例?"是 Polymarket 上一个拥有 11 个可能结果的预测市场,交易者根据自己的判断买卖份额。当前领先结果为"↑500",概率为 100%,其次是"↑1千",概率为 100%。价格反映社区的实时概率。例如,价格为 100¢ 的份额意味着市场集体认为该结果的概率为 100%。这些赔率会随着交易者的反应而不断变化。正确结果的份额在市场结算时可兑换为每份 $1。

截至目前,"2026年美国麻疹病例?"已产生 $7.8 million 的总交易量(自Dec 1, 2025市场上线以来)。这一活跃度反映了 Polymarket 社区的高度参与,并确保当前赔率由广泛的市场参与者共同形成。你可以直接在本页追踪实时价格变动并交易任何结果。

要在"2026年美国麻疹病例?"上交易,浏览本页上列出的 11 个可用结果。每个结果显示一个代表市场隐含概率的当前价格。要建仓,选择你认为最可能的结果,选择"是"支持或"否"反对,输入金额并点击"交易"。如果你选择的结果在市场结算时正确,你的"是"份额每份支付 $1。如果不正确,支付 $0。你也可以在结算前随时卖出份额。

"2026年美国麻疹病例?"的当前领先者是"↑500",概率为 100%,意味着市场对该结果的概率评估为 100%。紧随其后的结果是"↑1千",概率为 100%。这些赔率随着交易者买卖份额而实时更新。请经常回来查看或将本页加入书签。

"2026年美国麻疹病例?"的结算规则明确定义了每个结果被宣布为获胜者所需满足的条件——包括用于确定结果的官方数据来源。你可以在本页评论上方的"规则"部分查看完整的结算标准。我们建议在交易前仔细阅读规则,因为它们规定了精确的条件、特殊情况和数据来源。